fromArs Technica
1 week agoBiotech company Regeneron to buy bankrupt 23andMe for $256M
As a world leader in human genetics, Regeneron Genetics Center is committed to and has a proven track record of safeguarding the genetic data of people across the globe, and, with their consent, using this data to pursue discoveries that benefit science and society.
Privacy professionals